{"product_id":"nvec-vrio-analysis","title":"NVE Corporation (NVEC): VRIO Analysis [Mar-2026 Updated]","description":"\u003cbr\u003e\u003cp\u003eIs NVE Corporation (NVEC) truly built to last? Our VRIO analysis cuts straight to the core of its competitive edge, revealing that its current strengths are summarized by: \u0026amp;O4\u0026amp;. Dive in now to see exactly which resources give this business its staying power - or where the vulnerabilities lie.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eNVE Corporation (NVEC) - VRIO Analysis: \u003cstrong\u003e1. Spintronics Technology Leadership\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003cp\u003eYou’re looking at the core engine of NVE Corporation’s value proposition: their mastery of spintronics. This isn't just a feature; it’s a foundational technology that lets them build sensors and couplers that outperform conventional silicon-based parts on size, precision, and reliability. Honestly, this niche leadership is what allows them to command premium pricing, evidenced by their Q1 2025 gross margin hitting 86%.\u003c\/p\u003e\n\u003cp\u003eThe near-term risk is the cyclical nature of their product sales, which saw a 13% year-over-year revenue decrease to $25.9 million for the full fiscal year 2025, even though net income was still a solid $15.1 million. The action here is to watch how quickly the new wafer-level chip-scale products translate into revenue growth to capture that projected 15.1% CAGR in the broader spintronics market.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math on why this resource is hard to copy. It’s not just the patents; it’s the decade-plus of application know-how. Competitors can’t just buy the tech; they have to build the institutional knowledge, which takes years and serious capital commitment. What this estimate hides is the specific talent retention risk, but for now, the moat looks deep.\u003c\/p\u003e\n\u003cp\u003eThe company is clearly organized to defend this lead. They increased R\u0026amp;D expenditures by 33% in the past fiscal year to keep pushing the envelope on next-generation sensors and MRAM IP. This focus confirms the organization is aligned to exploit the technology’s value.\u003c\/p\u003e\n\u003cp\u003eWe map out the VRIO assessment below for clarity:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eVRIO Dimension\u003c\/td\u003e\n\u003ctd\u003eAssessment\u003c\/td\u003e\n\u003ctd\u003eSupporting Data\/Implication\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eValue (V)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eEnables smaller, more precise sensors; supported by high gross margins, e.g., 86% in Q1 2025.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRarity (R)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eLeading practical commercialization of spintronics nanotechnology in the sensor market.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eInimitability (I)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003ctd\u003eDeep, specialized knowledge base and years of application development are difficult to replicate.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eOrganization (O)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eStructure supports R\u0026amp;D; R\u0026amp;D spending increased 33% in fiscal 2025.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompetitive Advantage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSustained\u003c\/td\u003e\n\u003ctd\u003eCore technology platform is embedded and continually advanced through focused investment.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe immediate action is for the R\u0026amp;D team to ensure the new wafer-level chip-scale capacity expansion translates into design wins within the next two quarters to reverse the recent product sales slump.\u003c\/p\u003e\n\u003cp\u003eFinance: Draft a sensitivity analysis on the dividend payout versus the 33% R\u0026amp;D spend increase by next Wednesday.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eNVE Corporation (NVEC) - VRIO Analysis: \u003cstrong\u003e2. Proprietary Sensor \u0026amp; Coupler Product Portfolio\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Provides immediate revenue streams from high-value applications in factory automation, industrial networks, and medical devices. Product sales accounted for \u003cstrong\u003e96.7%\u003c\/strong\u003e of total revenue in the quarter ended September 30, 2025. For the fiscal year 2024, NVE Corporation's revenue was approximately \u003cstrong\u003e$140.00 Million\u003c\/strong\u003e. The company has historically secured over \u003cstrong\u003e$50 million\u003c\/strong\u003e in government research contracts to develop this portfolio.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Moderate; while others make sensors, NVE Corporation’s specific, high-performance GMR\/TMR sensor and coupler designs are unique. Competitors in the TMR market include TDK and Infineon Technologies. NVE's TMR segment is projected to exhibit the fastest CAGR in the broader Magnetic Sensor Market.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Temporary; competitors can develop similar products, but NVE Corporation’s current product generation has a lead time advantage. NVE introduced wafer-level chip-scale package (WLCSP) sensors as small as \u003cstrong\u003e0.6 x 0.6 mm\u003c\/strong\u003e. The overall TMR Sensors Market is projected to grow from \u003cstrong\u003eUS$ 239 million\u003c\/strong\u003e in 2024 to \u003cstrong\u003eUS$ 475 million\u003c\/strong\u003e by 2031.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Yes; they actively promote new products like wafer-level chip-scale sensors through trade shows and evaluation kits.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNew product announcements in 2025 included the 'World's Most Sensitive Off-Axis Rotation Sensor' and new GMR Magnetometer Sensors with ultrahigh temperature stability.\u003c\/li\u003e\n\u003cli\u003eEvaluation kits are available, such as breakout boards measuring \u003cstrong\u003e0.8 x 0.4 inch (21 x 10 mm)\u003c\/strong\u003e for WLCSP sensors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary; the specific product generation is protected by IP, but the product category itself is competitive.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eProduct\/Metric\u003c\/th\u003e\n\u003cth\u003eSpecification\/Value\u003c\/th\u003e\n\u003cth\u003eContext\/Series\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWLCSP Sensor Size\u003c\/td\u003e\n\u003ctd\u003eAs small as \u003cstrong\u003e0.6 x 0.6 mm\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eMiniaturization for industrial\/wearable applications\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTMR Sensor Sensitivity\u003c\/td\u003e\n\u003ctd\u003eUp to \u003cstrong\u003e500 mV\/V\/mT\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eALT-Series Analog Sensors\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGMR Switch Supply Current (Duty-Cycled)\u003c\/td\u003e\n\u003ctd\u003eAs low as \u003cstrong\u003e95 nanoamps (nA)\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eADL\/AHL-Series, at 2.4 V\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ2 FY2026 Net Income\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$3.31 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQuarter ended September 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ2 FY2026 Gross Margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e78%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDown from \u003cstrong\u003e86%\u003c\/strong\u003e in the prior-year quarter\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOutput Sink Current\u003c\/td\u003e\n\u003ctd\u003eUp to \u003cstrong\u003e100 microamps ($\\mu$A)\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eGMR Digital Switches\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cbr\u003e\u003ch2\u003eNVE Corporation (NVEC) - VRIO Analysis: \u003cstrong\u003e3. Advanced MRAM Intellectual Property\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003cp\u003eThe MRAM intellectual property portfolio is a core component of NVE Corporation's long-term strategy, distinct from its established sensor and isolator product lines.\u003c\/p\u003e\n\n\u003ch\u003eValue\u003c\/h\u003e\n\u003cp\u003ePositions NVE Corporation for future monetization through licensing to large manufacturers in the memory space, capitalizing on SRAM scaling limits.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe business model explicitly includes partnering with large-scale manufacturers to monetize MRAM intellectual property and advance the technology.\u003c\/li\u003e\n\u003cli\u003eMRAM technology is positioned as having advantages where SRAM runs into scaling limitations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch\u003eRarity\u003c\/h\u003e\n\u003cp\u003eHigh; patents on advanced MRAM designs like magnetothermal MRAM and spin-momentum MRAM are scarce.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMRAM IP Category\u003c\/th\u003e\n\u003cth\u003eSpecific Patent\/Development Mentioned\u003c\/th\u003e\n\u003cth\u003eAssociated Funding\/Date\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMagneto-thermal MRAM\u003c\/td\u003e\n\u003ctd\u003eU.S. Patent number \u003cstrong\u003e6,535,416\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eContract from DTRA for approximately \u003cstrong\u003e$500,000\u003c\/strong\u003e over two years (announced Nov 2003).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMagneto-thermal MRAM\u003c\/td\u003e\n\u003ctd\u003ePatent number \u003cstrong\u003e7,813,165\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eDevelopment continued under ONR funding, which brought total funding under that program to more than \u003cstrong\u003e$600,000\u003c\/strong\u003e (as of Oct 2005).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpin-momentum MRAM\u003c\/td\u003e\n\u003ctd\u003eSpin Torque MRAM \/ Spin Momentum MRAM\u003c\/td\u003e\n\u003ctd\u003eCEO confirmed ongoing focus on this area.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch\u003eImitability\u003c\/h\u003e\n\u003cp\u003eHigh; patents offer strong legal protection against direct imitation of the specific designs.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNVE technology is protected by more than \u003cstrong\u003e100\u003c\/strong\u003e patents worldwide either issued, pending or licensed from others (as of 2006).\u003c\/li\u003e\n\u003cli\u003eAs of March 31, 2022, NVE had more than \u003cstrong\u003e50\u003c\/strong\u003e issued U.S. patents assigned to them.\u003c\/li\u003e\n\u003cli\u003eTotal Active Patents were reported as \u003cstrong\u003e47\u003c\/strong\u003e (as of 2023).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch\u003eOrganization\u003c\/h\u003e\n\u003cp\u003eYes; the business model explicitly includes partnering to monetize this IP, viewing R\u0026amp;D contracts as a way to build this portfolio.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNVE has licensed its MRAM intellectual property to several companies, including Motorola, Inc., and Cypress Semiconductor Corporation.\u003c\/li\u003e\n\u003cli\u003eMuch of the intellectual property was developed with U.S. Government support, with over \u003cstrong\u003e$50 million\u003c\/strong\u003e awarded in government research contracts since founding.\u003c\/li\u003e\n\u003cli\u003eContract R\u0026amp;D Revenue increased by \u003cstrong\u003e17%\u003c\/strong\u003e in Q2 2025 (year-over-year).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch\u003eCompetitive Advantage\u003c\/h\u003e\n\u003cp\u003eSustained; the patent portfolio provides a long-term option value, even if near-term revenue is small.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eFinancial Metric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003cth\u003eFiscal Period Reference\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Revenue\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$25.9 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFiscal Year 2025 (ended March 31, 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Income\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$15.1 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFiscal Year 2025 (ended March 31, 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Margin\u003c\/td\u003e\n\u003ctd\u003eApproximately \u003cstrong\u003e58%\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eFiscal Year 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Income\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$3.58 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ2 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cbr\u003e\u003ch2\u003eNVE Corporation (NVEC) - VRIO Analysis: \u003cstrong\u003e4. In-House Wafer-Level Chip-Scale Manufacturing Capability\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Enables in-house production of smaller, more precise parts, reducing reliance on external specialized fabrication and improving quality control. New wafer-level chip scale sensors are described as being \u003cstrong\u003eless than 1,000th of a square inch\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e While many semiconductor firms fabricate wafers, having this capability specifically for their niche spintronic devices in-house is less common for a company of this size.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Temporary; competitors could build or acquire similar capacity, but the learning curve for NVE Corporation’s specific processes is a barrier.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Yes; the company has made significant capital investments to bring this capability in-house.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eInvestment Metric\u003c\/th\u003e\n\u003cth\u003eAmount\/Range\u003c\/th\u003e\n\u003cth\u003eFiscal Period\/Context\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Planned CapEx\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$4 million to $5 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFiscal Years 2025 and 2026 combined.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlanned CapEx\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$2 million to $3 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFiscal 2026, with largest portion for wafer fabrication equipment.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapEx Spent (Partial)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.13 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFirst half of Fiscal 2025, largely as down payments.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFixed Asset Purchases (Wafer Fab Equipment)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.06 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFirst Quarter of Fiscal 2026.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExpected Tax Credits\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$700,000 to $800,000\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFiscal 2026, contingent on equipment deployment.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary; it offers a short-term operational edge until competitors catch up on process integration, supported by the completion of a \u003cstrong\u003emultimillion-dollar\u003c\/strong\u003e expansion.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe in-house capability allows for the production of wafer-level chip scale parts, which are the world's smallest devices of their type.\u003c\/li\u003e\n\u003cli\u003eThe strategic investment aims to enhance self-sufficiency and capture more value by eliminating the need for outsourced packaging.\u003c\/li\u003e\n\u003cli\u003eThe company completed major capital investments in wafer fabrication equipment, expediting delivery prior to a tariff deadline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eNVE Corporation (NVEC) - VRIO Analysis: \u003cstrong\u003e5. Direct Sales Channel \u0026amp; High-Margin Focus\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003ch3\u003eValue\u003c\/h3\u003e\n\u003cp\u003eDirect sales channel focus directly translates to superior profitability. This is evidenced by the gross margin reaching \u003cstrong\u003e84%\u003c\/strong\u003e in Q3 Fiscal 2025, which was noted as being higher than that achieved through distributor sales.\u003c\/p\u003e\n\u003ch3\u003eRarity\u003c\/h3\u003e\n\u003cp\u003eThe reliance on a strong direct sales channel is considered moderate in rarity, as many industrial technology firms exhibit a heavier dependence on third-party distributors, making a robust direct customer engagement model less common.\u003c\/p\u003e\n\u003ch3\u003eImitability\u003c\/h3\u003e\n\u003cp\u003eThe advantage derived from established direct customer relationships is considered temporary. While competitors possess the capability to pivot their sales focus, the process of cultivating and embedding these direct customer relationships requires a significant, non-trivial investment of time.\u003c\/p\u003e\n\u003ch3\u003eOrganization\u003c\/h3\u003e\n\u003cp\u003eThe company demonstrates active management of its sales channel mix. This active management is visible in the financial reporting, as stronger distributor sales in Q1 Fiscal 2026 contributed to a contraction of the gross margin to \u003cstrong\u003e81%\u003c\/strong\u003e, down from a higher figure in the prior year period.\u003c\/p\u003e\n\u003cp\u003eThe impact of sales mix on profitability is summarized below:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003ePeriod\u003c\/th\u003e\n\u003cth\u003eGross Margin\u003c\/th\u003e\n\u003cth\u003eSales Mix Commentary\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 Fiscal 2025\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e84%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShift toward more profitable mix and increasing share of direct sales.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ1 Fiscal 2026\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e81%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAttributed to a less profitable product mix and stronger distributor sales with lower margins.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ1 Fiscal 2025 (Prior Year Q1)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e86%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHigher margin period preceding the shift in sales mix.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch3\u003eCompetitive Advantage\u003c\/h3\u003e\n\u003cp\u003eThe advantage is assessed as temporary. It functions as a structural benefit rooted in current operational execution but remains susceptible to erosion from unforeseen market shifts or proactive strategic adjustments by competing entities.\u003c\/p\u003e\n\u003cp\u003eKey characteristics related to the direct sales margin impact:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eStrengthening distributor sales in Q1 Fiscal 2026, a sign of improving industry conditions, correlated with a margin decrease to \u003cstrong\u003e81%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eDistributor sales inherently carry lower margins compared to direct sales transactions.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eNet income for Q1 Fiscal 2026 was \u003cstrong\u003e$3.58 million\u003c\/strong\u003e, or \u003cstrong\u003e$0.74\u003c\/strong\u003e per diluted share, compared to $4.10 million, or $0.85 per share, in the prior-year quarter.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eOperating margin for Q1 Fiscal 2026 was reported at \u003cstrong\u003e62%\u003c\/strong\u003e, with a net margin of \u003cstrong\u003e59%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eNVE Corporation (NVEC) - VRIO Analysis: \u003cstrong\u003e6. Strategic Customer Partnerships (e.g., Medical Sector)\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003ch\u003e\u003ch\u003eValue: Secures high-reliability, high-value design wins in critical sectors like medical devices, providing stable, less cyclical revenue.\u003c\/h\u003e\n\u003cp\u003eNVE Corporation develops technologies for high-value market opportunities such as the industrial internet of things and \u003cstrong\u003emedical devices\u003c\/strong\u003e. Medium-term product development programs in the past year included next-generation sensors for \u003cstrong\u003emedical devices\u003c\/strong\u003e and \u003cstrong\u003eimplanted medical devices\u003c\/strong\u003e. The company introduced multiple advanced magnetic sensor products targeting \u003cstrong\u003emedical devices\u003c\/strong\u003e in the fourth quarter of fiscal \u003cstrong\u003e2025\u003c\/strong\u003e. NVE relies on several large customers for a significant percentage of revenue, including \u003cstrong\u003eAbbott Laboratories\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch\u003e\u003ch\u003eRarity: Moderate; specific, long-term agreements with major players, like the extended partnership with Abbott Laboratories in 2025, are not easily replicated.\u003c\/h\u003e\n\u003cp\u003eIn \u003cstrong\u003e2025\u003c\/strong\u003e, NVE extended a partnering agreement with \u003cstrong\u003eAbbott Laboratories\u003c\/strong\u003e. The company also executed an extension of its supplier partnering agreement with \u003cstrong\u003eAbbott Laboratories\u003c\/strong\u003e in the fourth quarter of fiscal \u003cstrong\u003e2025\u003c\/strong\u003e. NVE's products are utilized in demanding applications, including \u003cstrong\u003emedical devices\u003c\/strong\u003e with stringent reliability and miniaturization, such as \u003cstrong\u003eimplants and hearing aids\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch\u003e\u003ch\u003eImitability: Sustained; these deep, qualified relationships act as high switching-cost barriers for competitors in regulated markets.\u003c\/h\u003e\n\u003cp\u003eThe company's focus on high-sensitivity sensors as a replacement for rare earth magnets supports its strategic positioning in advanced sensor markets, including \u003cstrong\u003emedical\u003c\/strong\u003e. The company's robust financial position is evidenced by a current ratio of \u003cstrong\u003e28.4\u003c\/strong\u003e, indicating exceptional liquidity to fund innovation initiatives.\u003c\/p\u003e\n\u003ch\u003e\u003ch\u003eOrganization: Yes; management explicitly highlights these partnerships as a key focus area for future growth.\u003c\/h\u003e\n\u003cp\u003eManagement has highlighted the company's focus on high-sensitivity sensors as a replacement for rare earth magnets, underscoring commitment to innovation. Management plans \u003cstrong\u003e$2 million to $3 million\u003c\/strong\u003e in capital expenditures for fiscal \u003cstrong\u003e2026\u003c\/strong\u003e, with a portion allocated for wafer fabrication equipment. The company has a track record of maintaining dividend payments for \u003cstrong\u003e11 consecutive years\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch\u003e\u003ch\u003eCompetitive Advantage: Sustained; embeddedness in customer products creates a sticky revenue base.\u003c\/h\u003e\n\u003cp\u003eThe company's annual revenue for the fiscal year ending March 31, \u003cstrong\u003e2025\u003c\/strong\u003e, was \u003cstrong\u003e$25.87M\u003c\/strong\u003e. For the fourth quarter of fiscal \u003cstrong\u003e2025\u003c\/strong\u003e, gross margin improved to \u003cstrong\u003e79%\u003c\/strong\u003e. Net income for the fourth quarter of fiscal \u003cstrong\u003e2025\u003c\/strong\u003e was \u003cstrong\u003e$3.89 million\u003c\/strong\u003e, or \u003cstrong\u003e$0.80\u003c\/strong\u003e per diluted share.\u003c\/p\u003e\n\u003cp\u003eThe following table summarizes the VRIO assessment components:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eVRIO Attribute\u003c\/th\u003e\n\u003cth\u003eAssessment\u003c\/th\u003e\n\u003cth\u003eSupporting Data\/Context\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eDevelops technology for \u003cstrong\u003emedical devices\u003c\/strong\u003e; next-gen sensors in development for \u003cstrong\u003eimplanted medical devices\u003c\/strong\u003e.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRarity\u003c\/td\u003e\n\u003ctd\u003eModerate\u003c\/td\u003e\n\u003ctd\u003eExtended partnering agreement with \u003cstrong\u003eAbbott Laboratories\u003c\/strong\u003e in \u003cstrong\u003e2025\u003c\/strong\u003e.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInimitability\u003c\/td\u003e\n\u003ctd\u003eHigh (Implied by Regulation\/Qualification)\u003c\/td\u003e\n\u003ctd\u003eProducts used in stringent reliability applications like \u003cstrong\u003eimplants and hearing aids\u003c\/strong\u003e.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrganization\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eManagement emphasizes focus on high-sensitivity sensors for markets including \u003cstrong\u003emedical\u003c\/strong\u003e. CapEx planned for \u003cstrong\u003e$2 million to $3 million\u003c\/strong\u003e in fiscal \u003cstrong\u003e2026\u003c\/strong\u003e.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompetitive Advantage\u003c\/td\u003e\n\u003ctd\u003eSustained\u003c\/td\u003e\n\u003ctd\u003eFiscal \u003cstrong\u003e2025\u003c\/strong\u003e annual revenue: \u003cstrong\u003e$25.87M\u003c\/strong\u003e. Q4 \u003cstrong\u003e2025\u003c\/strong\u003e Gross Margin: \u003cstrong\u003e79%\u003c\/strong\u003e.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eSpecific financial and operational data points related to the medical sector focus include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eIn the second quarter of fiscal \u003cstrong\u003e2025\u003c\/strong\u003e, total revenue decreased by \u003cstrong\u003e10%\u003c\/strong\u003e year-over-year, with product sales falling by \u003cstrong\u003e11%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eProduct sales saw a sequential increase of \u003cstrong\u003e40%\u003c\/strong\u003e in the fourth quarter of fiscal \u003cstrong\u003e2025\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D expenditures increased by \u003cstrong\u003e33%\u003c\/strong\u003e in the past fiscal year to support future growth, including medical sensor development.\u003c\/li\u003e\n\u003cli\u003eThe company's dividend has been maintained for \u003cstrong\u003e11 consecutive years\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eNVE's products are used in applications where size, precision, and temperature stability matter more than price.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eNVE Corporation (NVEC) - VRIO Analysis: \u003cstrong\u003e7. Strong Balance Sheet\/Liquidity\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003cp\u003e\nValue: Provides financial flexibility to fund R\u0026amp;D, maintain the \u003cstrong\u003e$1.00\u003c\/strong\u003e per share dividend, and weather industry downturns without distress.\n\u003c\/p\u003e\n\u003cp\u003e\nRarity: Moderate; an exceptional current ratio of \u003cstrong\u003e16.1\u003c\/strong\u003e is rare and signals robust short-term financial health.\n\u003c\/p\u003e\n\u003cp\u003e\nImitability: Temporary; competitors can improve liquidity through retained earnings or financing, but this level is high.\n\u003c\/p\u003e\n\u003cp\u003e\nOrganization: Yes; disciplined operations allowed net income for the first nine months of fiscal 2025 to be \u003cstrong\u003e$11.2 million\u003c\/strong\u003e despite revenue dips.\n\u003c\/p\u003e\n\u003cp\u003e\nCompetitive Advantage: Temporary; while strong, it is a financial metric that can change over time.\n\u003c\/p\u003e\n\u003cp\u003e\n\u003cstrong\u003eKey Financial Health Indicators:\u003c\/strong\u003e\n\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eQuarterly cash dividend announced at \u003cstrong\u003e$1.00\u003c\/strong\u003e per share of common stock.\u003c\/li\u003e\n\u003cli\u003eNet income for the first nine months of fiscal 2025 was \u003cstrong\u003e$11.2 million\u003c\/strong\u003e, or \u003cstrong\u003e$2.31\u003c\/strong\u003e per diluted share.\u003c\/li\u003e\n\u003cli\u003eReported dividend yield of \u003cstrong\u003e5.56%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003cth\u003ePeriod\/Context\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCurrent Ratio (TTM)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e29.64\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLatest reported TTM data\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCurrent Ratio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e16.1\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eReported in Q2 2025 context\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDebt \/ Equity Ratio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e0.02\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLatest reported data\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Income\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$11.2 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFirst nine months of fiscal 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDividend Yield\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.56%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eReported value\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cbr\u003e\u003ch2\u003eNVE Corporation (NVEC) - VRIO Analysis: \u003cstrong\u003e8. High Profitability\/Margin Structure\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Allows NVE Corporation to generate significant cash flow and report solid earnings even when top-line revenue is declining, as seen in FY2025. For the nine months ended December 31, 2024 (part of FY2025), Total Revenue was $\\mathbf{\\$18.604979 \\text{ million}}$, while Net Income was $\\mathbf{\\$11.172142 \\text{ million}}$. The TTM Revenue for 2025 was $\\mathbf{\\$24.78 \\text{ Million USD}}$.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e High; maintaining a gross margin near $\\mathbf{85\\%}$ while navigating industry weakness is exceptional. For the nine months ended December 31, 2024, the Gross Profit was $\\mathbf{\\$15.884609 \\text{ million}}$ on $\\mathbf{\\$18.604979 \\text{ million}}$ in revenue, equating to approximately $\\mathbf{85.37\\%}$ gross margin.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Temporary; high margins attract competition, and the margin has shown slight contraction recently. The Gross Margin decreased to $\\mathbf{78\\%}$ in Q2 FY2026 from $\\mathbf{86\\%}$ in the prior year quarter.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Yes; management prioritizes a profitable product mix and direct sales to defend these margins.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe company's board declared a quarterly cash dividend of $\\mathbf{\\$1.00}$ per share.\u003c\/li\u003e\n\u003cli\u003eTotal expenses decreased $\\mathbf{7\\%}$ in Q2 FY2026 compared to Q2 FY2025, driven by a $\\mathbf{23\\%}$ decrease in SG\u0026amp;A.\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D expenses increased by $\\mathbf{3\\%}$ in Q2 FY2026.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary; it’s a performance result that competitors will actively try to match.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eQ2 FY2025 (Prior Year)\u003c\/td\u003e\n\u003ctd\u003eQ2 FY2026 (Current)\u003c\/td\u003e\n\u003ctd\u003e9 Months Ended Dec 31, 2024 (FY2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross Margin\u003c\/td\u003e\n\u003ctd\u003e$\\mathbf{86\\%}$\u003c\/td\u003e\n\u003ctd\u003e$\\mathbf{78\\%}$\u003c\/td\u003e\n\u003ctd\u003e$\\approx \\mathbf{85.37\\%}$\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Income\u003c\/td\u003e\n\u003ctd\u003e$\\mathbf{\\$4.03 \\text{ million}}$\u003c\/td\u003e\n\u003ctd\u003e$\\mathbf{\\$3.31 \\text{ million}}$\u003c\/td\u003e\n\u003ctd\u003e$\\mathbf{\\$11.172142 \\text{ million}}$\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperating Margin\u003c\/td\u003e\n\u003ctd\u003eNot explicitly stated\u003c\/td\u003e\n\u003ctd\u003e$\\mathbf{58\\%}$\u003c\/td\u003e\n\u003ctd\u003eNot explicitly stated\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue Change (YoY)\u003c\/td\u003e\n\u003ctd\u003eNot explicitly stated\u003c\/td\u003e\n\u003ctd\u003e$\\mathbf{-6\\%}$\u003c\/td\u003e\n\u003ctd\u003e$\\mathbf{-18\\%}$\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cbr\u003e\u003ch2\u003eNVE Corporation (NVEC) - VRIO Analysis: \u003cstrong\u003e9. IP Developed with U.S. Government Support\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProvides a unique origin story and potential pre-validation for certain technologies, particularly in defense and anti-tamper applications. This support has been substantial, with the company having been awarded more than $50 million in government research contracts since its founding in 1989.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHigh; the specific history of government-supported development for key patents is not common across all tech firms. This history underpins core technology development, such as MRAM patent number 7,715,228, which was invented with U.S. Government support under a Missile Defense Agency contract.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSustained; the historical relationship and the resulting IP cannot be imitated, only licensed or designed around. The foundation built through these contracts is non-replicable in its historical context.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes; management views contract R\u0026amp;D as a strategic way to build the IP portfolio without direct expense hitting the bottom line. The organization actively pursues this avenue, as evidenced by the Contract R\u0026amp;D revenue trends:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eContract R\u0026amp;D revenue increased by 17% year-over-year in the second quarter of fiscal 2025.\u003c\/li\u003e\n\u003cli\u003eConversely, contract research and development revenue decreased by 92% in the second quarter of fiscal 2024 compared to the prior-year quarter.\u003c\/li\u003e\n\u003cli\u003eFor the first six months of fiscal 2024, contract research and development revenue decreased by 68% year-over-year.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSustained; this historical backing provides a unique, non-replicable foundation for specific product lines, including defense applications. Defense product sales represented 8% of total revenue in the most recently reported quarter (Q2 2025).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFinance\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFinancial metrics related to government\/defense work and overall financial health supporting R\u0026amp;D investment:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eFinancial Metric\u003c\/td\u003e\n\u003ctd\u003eAmount\/Percentage\u003c\/td\u003e\n\u003ctd\u003ePeriod\/Context\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Government Research Contracts Awarded\u003c\/td\u003e\n\u003ctd\u003eMore than $50 million\u003c\/td\u003e\n\u003ctd\u003eSince founding in 1989\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDefense Product Sales (as % of Revenue)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e8%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePast Quarter (Q2 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContract R\u0026amp;D Revenue Change\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e+17%\u003c\/strong\u003e \/ \u003cstrong\u003e-92%\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eQ2 FY2025 \/ Q2 FY2024 YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Issued U.S. Patents\u003c\/td\u003e\n\u003ctd\u003eMore than 50\u003c\/td\u003e\n\u003ctd\u003eAs of March 31, 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePotential Tax Credits Anticipated\u003c\/td\u003e\n\u003ctd\u003e$700,000 to $800,000\u003c\/td\u003e\n\u003ctd\u003eComing quarters (as of July 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\u003c\/h\u003e\u003c\/h\u003e\u003c\/h\u003e\u003c\/h\u003e\u003c\/h\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45516219842709,"sku":"nvec-vrio-analysis","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/nvec-vrio-analysis.png?v=1740200888","url":"https:\/\/dcf-model.com\/products\/nvec-vrio-analysis","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}